INT MEDICAL (01501) announced that the company has applied to the China Securities Regulatory Commission (CSRC) on behalf of twelve shareholders for the conversion of a total of 71,786,608 domestic shares held by them into H-shares. The board of directors announced that on May 9, 2026, the company received a filing notice for the full circulation of its domestic unlisted shares, issued by the CSRC regarding the H-share full circulation. The notice is dated April 27, 2026.